{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T23:07:25Z","timestamp":1768259245060,"version":"3.49.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI143567"],"award-info":[{"award-number":["R01AI143567"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RD16CIII\/0002\/0001"],"award-info":[{"award-number":["RD16CIII\/0002\/0001"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["FIS PI16CIII\/00034-ISCIII-FEDER"],"award-info":[{"award-number":["FIS PI16CIII\/00034-ISCIII-FEDER"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-110275RB-I00"],"award-info":[{"award-number":["PID2019-110275RB-I00"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bcp.2021.114666","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T05:55:05Z","timestamp":1624686905000},"page":"114666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy"],"prefix":"10.1016","volume":"192","author":[{"given":"Lorena","family":"Vig\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Mart\u00ednez-Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Rodr\u00edguez-Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda C.","family":"Puertas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"S\u00e1nchez-Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Ambrosioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Cervero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Wyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Alcam\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Podzamczer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valent\u00edn","family":"Garc\u00eda-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Mart\u00ednez-Picado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Briz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Rosa L\u00f3pez-Huertas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Planelles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayte","family":"Coiras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Corona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"del Mar D\u00edaz-Goizueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Knops","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Luna de Abia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz","family":"Mart\u00edn-Carbonero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Spivak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5341","key":"10.1016\/j.bcp.2021.114666_b0005","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"issue":"5341","key":"10.1016\/j.bcp.2021.114666_b0010","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia","volume":"278","author":"Wong","year":"1997","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.bcp.2021.114666_b0015","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy","volume":"94","author":"Chun","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"10","key":"10.1016\/j.bcp.2021.114666_b0020","doi-asserted-by":"crossref","first-page":"e1000533","DOI":"10.1371\/journal.pcbi.1000533","article-title":"Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy","volume":"5","author":"Rong","year":"2009","journal-title":"PLoS Comput. Biol."},{"issue":"6756","key":"10.1016\/j.bcp.2021.114666_b0025","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/44755","article-title":"Re-emergence of HIV after stopping therapy","volume":"401","author":"Chun","year":"1999","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.bcp.2021.114666_b0030","doi-asserted-by":"crossref","first-page":"15109","DOI":"10.1073\/pnas.96.26.15109","article-title":"HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression","volume":"96","author":"Davey","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4","key":"10.1016\/j.bcp.2021.114666_b0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00002030-200003100-00013","article-title":"Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression","volume":"14","author":"Ruiz","year":"2000","journal-title":"AIDS"},{"issue":"24","key":"10.1016\/j.bcp.2021.114666_b0040","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1120248109","article-title":"Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection","volume":"109","author":"Archin","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.bcp.2021.114666_b0045","unstructured":"A. Cheret, C. Bacchus-Souffan, V. Avettand-Fenoel, A. Melard, G. Nembot, C. Blanc, A. Samri, A. Saez-Cirion, L. Hocqueloux, C. Lascoux-Combe, C. Allavena, C. Goujard, M.A. Valantin, A. Leplatois, L. Meyer, C. Rouzioux, B. Autran, O.A.-S. Group, Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission, J Antimicrob Chemother 70(7) (2015) 2108-20."},{"key":"10.1016\/j.bcp.2021.114666_b0050","doi-asserted-by":"crossref","unstructured":"C. Goujard, I. Girault, C. Rouzioux, C. Lecuroux, C. Deveau, M.L. Chaix, C. Jacomet, A. Talamali, J.F. Delfraissy, A. Venet, L. Meyer, M. Sinet, A.C.P.S. Group, HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy, Antivir Ther 17(6) (2012) 1001-9.","DOI":"10.3851\/IMP2273"},{"issue":"16","key":"10.1016\/j.bcp.2021.114666_b0055","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archinternmed.2012.2719","article-title":"Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion","volume":"172","author":"Lodi","year":"2012","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.bcp.2021.114666_b0060","doi-asserted-by":"crossref","first-page":"e100321","DOI":"10.1371\/journal.ppat.1003211","article-title":"Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study","volume":"9","author":"S\u00e1ez-Ciri\u00f3n","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bcp.2021.114666_b0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1742-4690-8-97","article-title":"Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy","volume":"8","author":"Salgado","year":"2011","journal-title":"Retrovirology"},{"issue":"2","key":"10.1016\/j.bcp.2021.114666_b0070","first-page":"245","article-title":"Mechanisms of virologic control and clinical characteristics of HIV+ Elite\/Viremic controllers","volume":"90","author":"Gonzalo-Gil","year":"2017","journal-title":"Yale J. Biol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2021.114666_b0075","first-page":"123","article-title":"Rouzioux, Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection","volume":"14","author":"Hubert","year":"2000","journal-title":"The SEROCO Study Group, AIDS"},{"key":"10.1016\/j.bcp.2021.114666_b0080","doi-asserted-by":"crossref","unstructured":"O. Lambotte, F. Boufassa, Y. Madec, A. Nguyen, C. Goujard, L. Meyer, C. Rouzioux, A. Venet, J.F. Delfraissy, S.-H.S. Group, HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication, Clin Infect Dis 41(7) (2005) 1053-6.","DOI":"10.1086\/433188"},{"issue":"4","key":"10.1016\/j.bcp.2021.114666_b0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJM199501263320401","article-title":"Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection","volume":"332","author":"Cao","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bcp.2021.114666_b0090","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00042560-199504120-00010","article-title":"Long-term survivors with HIV-1 infection: Incubation period and longitudinal patterns of CD4+ lymphocytes","volume":"8","author":"Munoz","year":"1995","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114666_b0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199501263320402","article-title":"Studies in subjects with long-term nonprogressive human immunodeficiency virus infection","volume":"332","author":"Pantaleo","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"7512","key":"10.1016\/j.bcp.2021.114666_b0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nature13647","article-title":"HIV: Early treatment may not be early enough","volume":"512","author":"Deng","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2021.114666_b0105","doi-asserted-by":"crossref","unstructured":"A.S.S.W.G.o.H.I.V.C. International, S.G. Deeks, B. Autran, B. Berkhout, M. Benkirane, S. Cairns, N. Chomont, T.W. Chun, M. Churchill, M. Di Mascio, C. Katlama, A. Lafeuillade, A. Landay, M. Lederman, S.R. Lewin, F. Maldarelli, D. Margolis, M. Markowitz, J. Martinez-Picado, J.I. Mullins, J. Mellors, S. Moreno, U. O'Doherty, S. Palmer, M.C. Penicaud, M. Peterlin, G. Poli, J.P. Routy, C. Rouzioux, G. Silvestri, M. Stevenson, A. Telenti, C. Van Lint, E. Verdin, A. Woolfrey, J. Zaia, F. Barre-Sinoussi, Towards an HIV cure: a global scientific strategy, Nat Rev Immunol 12(8) (2012) 607-14.","DOI":"10.1038\/nri3262"},{"key":"10.1016\/j.bcp.2021.114666_b0110","doi-asserted-by":"crossref","unstructured":"J. Ananworanich, N. Chomont, L.A. Eller, E. Kroon, S. Tovanabutra, M. Bose, M. Nau, J.L.K. Fletcher, S. Tipsuk, C. Vandergeeten, R.J. O'Connell, S. Pinyakorn, N. Michael, N. Phanuphak, M.L. Robb, Rv, R.S.s. groups, HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART, EBioMedicine 11 (2016) 68-72.","DOI":"10.1016\/j.ebiom.2016.07.024"},{"key":"10.1016\/j.bcp.2021.114666_b0115","doi-asserted-by":"crossref","unstructured":"J.B. Whitney, A.L. Hill, S. Sanisetty, P. Penaloza-MacMaster, J. Liu, M. Shetty, L. Parenteau, C. Cabral, J. Shields, S. Blackmore, J.Y. Smith, A.L. Brinkman, L.E. Peter, S.I. Mathew, K.M. Smith, E.N. Borducchi, D.I. Rosenbloom, M.G. Lewis, J. Hattersley, B. Li, J. Hesselgesser, R. Geleziunas, M.L. Robb, J.H. Kim, N.L. Michael, D.H. Barouch, Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys, Nature 512(7512) (2014) 74-7.","DOI":"10.1038\/nature13594"},{"issue":"9","key":"10.1016\/j.bcp.2021.114666_b0120","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/infdis\/jiv218","article-title":"Precise quantitation of the latent HIV-1 reservoir: Implications for eradication strategies","volume":"212","author":"Crooks","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bcp.2021.114666_b0125","doi-asserted-by":"crossref","unstructured":"J.D. Siliciano, J. Kajdas, D. Finzi, T.C. Quinn, K. Chadwick, J.B. Margolick, C. Kovacs, S.J. Gange, R.F. Siliciano, Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells, Nat Med 9(6) (2003) 727-8.","DOI":"10.1038\/nm880"},{"key":"10.1016\/j.bcp.2021.114666_b0130","first-page":"131","article-title":"Mathematical Models of HIV Latency","volume":"417","author":"Hill","year":"2018","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"10.1016\/j.bcp.2021.114666_b0135","doi-asserted-by":"crossref","unstructured":"N. Chomont, M. El-Far, P. Ancuta, L. Trautmann, F.A. Procopio, B. Yassine-Diab, G. Boucher, M.R. Boulassel, G. Ghattas, J.M. Brenchley, T.W. Schacker, B.J. Hill, D.C. Douek, J.P. Routy, E.K. Haddad, R.P. Sekaly, HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation, Nat Med 15(8) (2009) 893-900.","DOI":"10.1038\/nm.1972"},{"key":"10.1016\/j.bcp.2021.114666_b0140","doi-asserted-by":"crossref","unstructured":"F. Maldarelli, X. Wu, L. Su, F.R. Simonetti, W. Shao, S. Hill, J. Spindler, A.L. Ferris, J.W. Mellors, M.F. Kearney, J.M. Coffin, S.H. Hughes, HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells, Science 345(6193) (2014) 179-83.","DOI":"10.1126\/science.1254194"},{"key":"10.1016\/j.bcp.2021.114666_b0145","unstructured":"FDA, The FDA approves new leukemia drug; expands use of current drug, FDA Consum 40(6) (2006) 5."},{"issue":"1","key":"10.1016\/j.bcp.2021.114666_b0150","first-page":"1","article-title":"Current perspectives for the treatment of chronic myeloid leukemia","volume":"49","author":"Aladag","year":"2019","journal-title":"Turk J. Med. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2021.114666_b0155","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11904-019-00462-5","article-title":"Tyrosine kinase inhibition: A new perspective in the fight against HIV","volume":"16","author":"Rodriguez-Mora","year":"2019","journal-title":"Curr HIV\/AIDS Rep."},{"key":"10.1016\/j.bcp.2021.114666_b0160","doi-asserted-by":"crossref","unstructured":"M. Bermejo, J. Ambrosioni, G. Bautista, N. Climent, E. Mateos, C. Rovira, S. Rodriguez-Mora, M.R. Lopez-Huertas, V. Garcia-Gutierrez, J.L. Steegmann, R. Duarte, F. Cervantes, M. Plana, J.M. Miro, J. Alcami, M. Coiras, Evaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors, Biochem Pharmacol 156 (2018) 248-264.","DOI":"10.1016\/j.bcp.2018.08.031"},{"issue":"4","key":"10.1016\/j.bcp.2021.114666_b0165","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.celrep.2013.03.017","article-title":"Phosphorylation of SAMHD1 by cyclin A2\/CDK1 regulates its restriction activity toward HIV-1","volume":"3","author":"Cribier","year":"2013","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.bcp.2021.114666_b0170","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.celrep.2016.02.022","article-title":"IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle","volume":"14","author":"Coiras","year":"2016","journal-title":"Cell Rep"},{"issue":"suppl 2","key":"10.1016\/j.bcp.2021.114666_b0175","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1093\/infdis\/jiw287","article-title":"Cytokines and T-cell homeostasis in HIV infection","volume":"214","author":"Freeman","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.bcp.2021.114666_b0180","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/leu.2015.73","article-title":"The EUTOS population-based registry: Incidence and clinical characteristics of 2904 CML patients in 20 European Countries","volume":"29","author":"Hoffmann","year":"2015","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.bcp.2021.114666_b0185","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.leukres.2012.07.012","article-title":"Human immunodeficiency virus infection and chronic myeloid leukemia","volume":"36","author":"Patel","year":"2012","journal-title":"Leuk Res."},{"issue":"4","key":"10.1016\/j.bcp.2021.114666_b0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.rce.2014.01.025","article-title":"Chronic myeloid leukemia treatment and human immunodeficiency virus infection","volume":"214","author":"Campillo-Recio","year":"2014","journal-title":"Rev. Clin. Esp. (Barc)"},{"key":"10.1016\/j.bcp.2021.114666_b0195","doi-asserted-by":"crossref","unstructured":"X. de la Tribonniere, R. Leberre, I. Plantier, S. Alfandari, C. Beuscart, J.P. Jouet, Y. Mouton, Chronic myelogenous leukemia in an HIV-infected patient, Infection 26(3) (1998) 194.","DOI":"10.1007\/BF02771855"},{"issue":"3","key":"10.1016\/j.bcp.2021.114666_b0200","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.inf.0000154324.59426.8d","article-title":"Malignancy in perinatally human immunodeficiency virus-infected children in the United States","volume":"24","author":"Kest","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.bcp.2021.114666_b0205","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/00002030-199009000-00016","article-title":"Chronic myeloid leukemia in a homosexual HIV-seropositive man","volume":"4","author":"Lorand-Metze","year":"1990","journal-title":"AIDS"},{"issue":"1-2","key":"10.1016\/j.bcp.2021.114666_b0210","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/10428199709109178","article-title":"Improving the cytogenetic response to interferon alpha by zidovudine (AZT) in an HIV-positive chronic myelogenous leukemia patient","volume":"26","author":"Mahon","year":"1997","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.bcp.2021.114666_b0215","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1080\/10428190802074601","article-title":"Chronic myeloid leukemia and HIV-infection","volume":"49","author":"Schlaberg","year":"2008","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"10.1016\/j.bcp.2021.114666_b0220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00126334-200007010-00017","article-title":"Successful allogeneic bone marrow transplant in an HIV-1-positive man with chronic myelogenous leukemia","volume":"24","author":"Schlegel","year":"2000","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"4","key":"10.1016\/j.bcp.2021.114666_b0225","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/pbc.22096","article-title":"Prolonged chronic phase of greater than 10 years of chronic myelogenous leukemia in a patient with congenital human immunodefeciency virus infection","volume":"53","author":"Setty","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.bcp.2021.114666_b0230","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.leukres.2003.10.020","article-title":"Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature","volume":"28","author":"Tsimberidou","year":"2004","journal-title":"Leuk. Res."},{"issue":"4","key":"10.1016\/j.bcp.2021.114666_b0235","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/0971-5851.125259","article-title":"Human immunodeficiency virus Infection in a patient of chronic myelogenous leukemia","volume":"34","author":"Tuljapurkar","year":"2013","journal-title":"Indian J. Med. Paediatr. Oncol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114666_b0240","first-page":"292","article-title":"Pediatric HIV infection and chronic myelogenous leukemia","volume":"6","author":"Verneris","year":"1995","journal-title":"Pediatr. AIDS HIV Infect."},{"issue":"18","key":"10.1016\/j.bcp.2021.114666_b0245","doi-asserted-by":"crossref","first-page":"10119","DOI":"10.1128\/JVI.77.18.10119-10124.2003","article-title":"Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus","volume":"77","author":"Brussel","year":"2003","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.bcp.2021.114666_b0250","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1128\/JVI.80.8.3712-3720.2006","article-title":"Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex","volume":"80","author":"Dismuke","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114666_b0255","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1038\/s41598-017-09183-4","article-title":"Poisson plus quantification for digital PCR systems","volume":"7","author":"Majumdar","year":"2017","journal-title":"Sci. Rep."},{"issue":"6754","key":"10.1016\/j.bcp.2021.114666_b0260","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2021.114666_b0265","doi-asserted-by":"crossref","unstructured":"K.M. Bruner, Z. Wang, F.R. Simonetti, A.M. Bender, K.J. Kwon, S. Sengupta, E.J. Fray, S.A. Beg, A.A.R. Antar, K.M. Jenike, L.N. Bertagnolli, A.A. Capoferri, J.T. Kufera, A. Timmons, C. Nobles, J. Gregg, N. Wada, Y.C. Ho, H. Zhang, J.B. Margolick, J.N. Blankson, S.G. Deeks, F.D. Bushman, J.D. Siliciano, G.M. Laird, R.F. Siliciano, A quantitative approach for measuring the reservoir of latent HIV-1 proviruses, Nature 566(7742) (2019) 120-125.","DOI":"10.1038\/s41586-019-0898-8"},{"issue":"1","key":"10.1016\/j.bcp.2021.114666_b0270","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41467-020-20442-3","article-title":"HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)","volume":"12","author":"Kinloch","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bcp.2021.114666_b0275","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132997","article-title":"Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy","volume":"5","author":"Peluso","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.bcp.2021.114666_b0280","doi-asserted-by":"crossref","unstructured":"Y.C. Ho, L. Shan, N.N. Hosmane, J. Wang, S.B. Laskey, D.I. Rosenbloom, J. Lai, J.N. Blankson, J.D. Siliciano, R.F. Siliciano, Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure, Cell 155(3) (2013) 540-51.","DOI":"10.1016\/j.cell.2013.09.020"},{"issue":"5","key":"10.1016\/j.bcp.2021.114666_b0285","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7326\/M14-1027","article-title":"Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: Report of 2 cases","volume":"161","author":"Henrich","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bcp.2021.114666_b0290","doi-asserted-by":"crossref","unstructured":"K. Luzuriaga, H. Gay, C. Ziemniak, K.B. Sanborn, M. Somasundaran, K. Rainwater-Lovett, J.W. Mellors, D. Rosenbloom, D. Persaud, Viremic relapse after HIV-1 remission in a perinatally infected child, N Engl J Med 372(8) (2015) 786-8.","DOI":"10.1056\/NEJMc1413931"},{"key":"10.1016\/j.bcp.2021.114666_b0295","doi-asserted-by":"crossref","unstructured":"M. Bermejo, M.R. Lopez-Huertas, J. Garcia-Perez, N. Climent, B. Descours, J. Ambrosioni, E. Mateos, S. Rodriguez-Mora, L. Rus-Bercial, M. Benkirane, J.M. Miro, M. Plana, J. Alcami, M. Coiras, Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells, Biochem Pharmacol 106 (2016) 30-45.","DOI":"10.1016\/j.bcp.2016.02.002"},{"key":"10.1016\/j.bcp.2021.114666_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113625","article-title":"Dasatinib protects humanized mice from acute HIV-1 infection","volume":"174","author":"Salgado","year":"2020","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.bcp.2021.114666_b0305","doi-asserted-by":"crossref","unstructured":"D.A. Kulpa, A. Talla, J.H. Brehm, S.P. Ribeiro, S. Yuan, A.G. Bebin-Blackwell, M. Miller, R. Barnard, S.G. Deeks, D. Hazuda, N. Chomont, R.P. Sekaly, Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4(+) T Cells, J Virol 93(24) (2019).","DOI":"10.1128\/JVI.00969-19"},{"issue":"10","key":"10.1016\/j.bcp.2021.114666_b0310","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1086\/592716","article-title":"Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy","volume":"198","author":"Benito","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bcp.2021.114666_b0315","doi-asserted-by":"crossref","unstructured":"P. Tremeaux, T. Lenfant, F. Boufassa, A. Essat, A. Melard, M. Gousset, O. Delelis, J.P. Viard, M. Bary, C. Goujard, C. Rouzioux, L. Meyer, V. Avettand-Fenoel, S. Anrs, P. cohorts, Increasing contribution of integrated forms to total HIV DNA in blood during HIV disease progression from primary infection, EBioMedicine 41 (2019) 455-464.","DOI":"10.1016\/j.ebiom.2019.02.016"},{"issue":"11","key":"10.1016\/j.bcp.2021.114666_b0320","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/cid\/ciz108","article-title":"Naive CD4+ T cells harbor a large inducible reservoir of latent, replication-competent Human immunodeficiency virus type 1","volume":"69","author":"Zerbato","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.bcp.2021.114666_b0325","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1093\/cid\/ciz378","article-title":"Genetic evidence that naive T cells can contribute significantly to the human immunodeficiency virus intact reservoir: Time to re-evaluate their role","volume":"69","author":"Venanzi Rullo","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bcp.2021.114666_b0330","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jtbi.2012.12.025","article-title":"Quantifying T lymphocyte turnover","volume":"327","author":"De Boer","year":"2013","journal-title":"J. Theor. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114666_b0335","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.tim.2016.01.006","article-title":"HIV-1 Reservoirs during suppressive therapy","volume":"24","author":"Barton","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bcp.2021.114666_b0340","doi-asserted-by":"crossref","unstructured":"R. Lorenzo-Redondo, H.R. Fryer, T. Bedford, E.Y. Kim, J. Archer, S.L.K. Pond, Y.S. Chung, S. Penugonda, J. Chipman, C.V. Fletcher, T.W. Schacker, M.H. Malim, A. Rambaut, A.T. Haase, A.R. McLean, S.M. Wolinsky, Persistent HIV-1 replication maintains the tissue reservoir during therapy, Nature 530(7588) (2016) 51-56.","DOI":"10.1038\/nature16933"},{"key":"10.1016\/j.bcp.2021.114666_b0345","unstructured":"EMA, SPRYCEL EPAR Product information."},{"issue":"5","key":"10.1016\/j.bcp.2021.114666_b0350","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/14787210.2017.1308823","article-title":"Potential role of tyrosine kinase inhibitors during primary HIV-1 infection","volume":"15","author":"Ambrosioni","year":"2017","journal-title":"Expert. Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.bcp.2021.114666_b0355","unstructured":"EMEA, Sprycel: EPAR - Scientific Discussion, https:\/\/www.ema.europa.eu\/en\/medicines\/human (2006)."},{"key":"10.1016\/j.bcp.2021.114666_b0360","doi-asserted-by":"crossref","unstructured":"F.M. Johnson, S. Agrawal, H. Burris, L. Rosen, N. Dhillon, D. Hong, A. Blackwood-Chirchir, F.R. Luo, O. Sy, S. Kaul, A.A. Chiappori, Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors, Cancer 116(6) (2010) 1582-91.","DOI":"10.1002\/cncr.24927"},{"issue":"2","key":"10.1016\/j.bcp.2021.114666_b0365","first-page":"101","article-title":"Drug interactions with cobicistat- or ritonavir-boosted elvitegravir","volume":"18","author":"Nguyen","year":"2016","journal-title":"AIDS Rev"},{"issue":"3","key":"10.1016\/j.bcp.2021.114666_b0370","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s13181-015-0465-0","article-title":"A review of the toxicity of HIV medications II: Interactions with drugs and complementary and alternative medicine products","volume":"11","author":"Stolbach","year":"2015","journal-title":"J. Med. Toxicol."},{"issue":"10","key":"10.1016\/j.bcp.2021.114666_b0375","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/M18-0759","article-title":"Mechanisms that contribute to a profound reduction of the HIV-1 reservoir after allogeneic stem cell transplant","volume":"169","author":"Salgado","year":"2018","journal-title":"Ann. Intern. Med."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221002793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221002793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:09:16Z","timestamp":1762096156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221002793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":75,"alternative-id":["S0006295221002793"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114666","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114666"}}